| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/23/2002 | EP1173197A2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue |
| 01/23/2002 | EP1173196A1 New use of a substance in pns |
| 01/23/2002 | EP1173195A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/23/2002 | EP1173194A2 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
| 01/23/2002 | EP1173193A1 Desleucyl glycopeptide antibiotics and methods of making same |
| 01/23/2002 | EP1173192A2 Methods and compositions for targeted drug delivery |
| 01/23/2002 | EP1173191A1 Novel antiangiogenic peptide agents and their therapeutic and diagnostic use |
| 01/23/2002 | EP1173190A1 Treatment of acute myocardial infarction with a substance related to the growth hormone axis |
| 01/23/2002 | EP1173189A1 Asialocytokines and treatment of liver disease |
| 01/23/2002 | EP1173157A2 Treatment of trauma |
| 01/23/2002 | EP1173155A1 Gum pad for delivery of medication to mucosal tissues |
| 01/23/2002 | EP1173151A1 Dry, mouldable drug formulation |
| 01/23/2002 | EP1173145A1 Composition for cosmetic and dermatological skin care |
| 01/23/2002 | EP1173144A1 Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents |
| 01/23/2002 | EP1173061A1 Compositions and methods for treatment of hyperproliferative diseases |
| 01/23/2002 | EP1056856B1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 01/23/2002 | EP0980254B1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| 01/23/2002 | EP0884947A4 Dna vaccination for induction of suppressive t cell response |
| 01/23/2002 | EP0839046B1 Tnf receptor and steroid hormone dhea in a combined therapy |
| 01/23/2002 | EP0797590B1 Neurotrophic peptides of activity dependent neurotrophic factor |
| 01/23/2002 | EP0755258B1 Methods of treating disease using sertoli cells and allografts or xenografts |
| 01/23/2002 | EP0745093B1 New oligopeptides with affinity to opioid receptors |
| 01/23/2002 | EP0739903B1 Carbamoylmethylurea derivative |
| 01/23/2002 | EP0726771B1 Desferrioxamine oral delivery system |
| 01/23/2002 | EP0704056B9 Leukocyte adhesion assay |
| 01/23/2002 | EP0696205B1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 01/23/2002 | EP0623144B1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 01/23/2002 | CN1332803A Streptococcus antigens |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332799A Cancer cell vaccine |
| 01/23/2002 | CN1332737A Thrombin inhibitors |
| 01/23/2002 | CN1332729A 4-oxo-1,4-dihybro-3-quinolinecarboxamides as antiviral agents |
| 01/23/2002 | CN1332723A Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 01/23/2002 | CN1332636A Composition for prevention and/or |
| 01/23/2002 | CN1332635A Controlled release formulation comprising GnRH-II |
| 01/23/2002 | CN1332629A Pharmaceutical composition |
| 01/23/2002 | CN1332628A Method of treating sexual disturbances |
| 01/23/2002 | CN1332626A Inhalation system |
| 01/23/2002 | CN1332240A Superoxide dismutase-4 |
| 01/23/2002 | CN1332167A Eprosartan dihydrate and its prep. |
| 01/23/2002 | CN1331976A Traumtin prepn for injecta and its prepn process |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/23/2002 | CN1078074C Composition for treating and inhibiting gastric and duodenal ulcers |
| 01/23/2002 | CN1078042C Method for production of proteins in plant fluids |
| 01/22/2002 | USRE37525 Concurrent administration of acetylsalicylic acid, corticosteroid, indomethacin, or ibuprofen antiinflammatory agent and human immunoglobulin g to treat bronchiolitis caused by respiratory syncytial or parainfluenza virus |
| 01/22/2002 | US6340783 Infusing a proteoglycan with a beta-amyloid protein into brain tissue of rodents; allow the proteins to be co-deposited and detect amyloid deposits in the brain tissue using standard staining method for fibrillar amyloid |
| 01/22/2002 | US6340742 Erythropoietin conjugates |
| 01/22/2002 | US6340740 An isolated polypeptide involved in modulating apoptotis; therapy for acquired immunodeficiency syndrome (aids), nervous system disorders and ischemic injury |
| 01/22/2002 | US6340709 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 01/22/2002 | US6340673 Administering at or near a site of a tumor of tumorigenic disease a herpes simplex virus vector lacking an expressible .gamma..sub.1 34.5 gene, whereby the growth of tumor is suppressed |
| 01/22/2002 | US6340669 Lipoprotein complexes and compositions containing them |
| 01/22/2002 | US6340668 Administering bone morphogenetic protein-11 (bmp-11) to neuronal cells effective to promote the survival of cells |
| 01/22/2002 | US6340667 Contacting the bacteria or fungi with a bacterial of fungal cell killing effective amount of a fragment of reptilian hemoglobin protein, selected from reptilian heme-free hemoglobin .alpha. chain, a reptilia heme-free hemoglobin |
| 01/22/2002 | US6340575 An isolated nucleic acid encoding a ras superfamily, rac gene, that modulates gtpase activity; cancer therapy |
| 01/22/2002 | US6340461 For immunotherapy |
| 01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
| 01/22/2002 | US6340458 Use of enzymes for skin expansion |
| 01/22/2002 | CA2259962C Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/22/2002 | CA2192424C Novel paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
| 01/22/2002 | CA2190564C Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders |
| 01/22/2002 | CA2149333C Eck receptor ligands |
| 01/22/2002 | CA2107556C Increasing blood-brain barrier permeability with permeabilizer peptides |
| 01/22/2002 | CA2057711C Antibiotic agent |
| 01/22/2002 | CA2050304C Pharmaceutical composition useful in preventing or treating tumors induced by papillomaruses |
| 01/22/2002 | CA2038848C Hydantoin derivatives |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/22/2002 | CA2019974C Treatment of inflammation |
| 01/22/2002 | CA1341333C Amylin peptides and uses thereof |
| 01/17/2002 | WO2002004953A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 01/17/2002 | WO2002004952A2 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 01/17/2002 | WO2002004646A1 Expression system |
| 01/17/2002 | WO2002004643A1 Tumor necrosis factor-gamma |
| 01/17/2002 | WO2002004642A1 Novel polypeptide and dna thereof |
| 01/17/2002 | WO2002004641A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004640A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004636A1 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
| 01/17/2002 | WO2002004635A1 A novel polypeptide, a human mbll zinc finger protein 39 and the polynucleotide encoding the polypeptide |
| 01/17/2002 | WO2002004634A1 A novel polypeptide, a human apoptosis relative protein 9.46 and the polynucleotide encoding the polypeptide |
| 01/17/2002 | WO2002004633A1 A novel polypeptide, a human fascicular and elongation protein 12.87 and the polynucleotide encoding the polypeptide |
| 01/17/2002 | WO2002004632A1 A novel polypeptide, a human latexin protein 53 and the polynucleotide encoding the polypeptide |
| 01/17/2002 | WO2002004631A1 A novel polypeptide, a human l1 factor orf2 inverse transcription relative protein 11 and the polynucleotide encoding the polypeptide |
| 01/17/2002 | WO2002004626A1 Fungal cell wall synthesis gene |
| 01/17/2002 | WO2002004625A1 α-SYNUCLEIN BINDING PROTEIN |
| 01/17/2002 | WO2002004623A2 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
| 01/17/2002 | WO2002004616A1 RECOMBINANT α-L-IDURONIDASE, METHODS FOR PRODUCING AND PURIFYING THE SAME AND METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES THEREOF |
| 01/17/2002 | WO2002004613A2 Isolated polynucleotides encoding human 5'-nucleotide cn-ia and cn-ib, isolated proteins encoded by the same, and methods utilizing the same |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004611A2 Aminoacyl trna synthetases |
| 01/17/2002 | WO2002004610A2 Regulation of human dipeptidyl-peptidase iv-like enzyme |
| 01/17/2002 | WO2002004608A2 Regulation of human oligopeptidase a-like enzyme |
| 01/17/2002 | WO2002004605A2 Stimulation of cellular regeneration and differentiation in the inner ear |
| 01/17/2002 | WO2002004521A2 Proteins with integrin-like activity |
| 01/17/2002 | WO2002004520A2 Transporters and ion channels |
| 01/17/2002 | WO2002004518A2 Human neuropeptide y-like g protein-coupled receptor |
| 01/17/2002 | WO2002004516A2 Use of the heat shock protein gp96 |
| 01/17/2002 | WO2002004515A1 Insulin derivatives and synthesis thereof |
| 01/17/2002 | WO2002004514A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | WO2002004513A2 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | WO2002004512A2 Purification of human troponin i |
| 01/17/2002 | WO2002004511A2 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |